CIOLI, ELEONORA
 Distribuzione geografica
Continente #
EU - Europa 108
NA - Nord America 107
AS - Asia 33
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
OC - Oceania 1
Totale 258
Nazione #
US - Stati Uniti d'America 101
RU - Federazione Russa 61
IT - Italia 39
SG - Singapore 16
CN - Cina 6
GB - Regno Unito 4
HK - Hong Kong 4
CR - Costa Rica 3
VN - Vietnam 3
AT - Austria 2
BR - Brasile 2
FR - Francia 2
KR - Corea 2
AG - Antigua e Barbuda 1
AU - Australia 1
CL - Cile 1
GT - Guatemala 1
JM - Giamaica 1
JP - Giappone 1
PK - Pakistan 1
Totale 252
Città #
Moscow 22
San Jose 14
Ashburn 13
Council Bluffs 13
Singapore 10
Milan 9
Santa Clara 6
Rome 4
Hong Kong 3
Los Angeles 3
Naples 3
San José 3
Atlanta 2
Casalnuovo di Napoli 2
Castellammare di Stabia 2
Chicago 2
Ho Chi Minh City 2
Houston 2
Seoul 2
Aurora 1
Aversa 1
Bari 1
Beijing 1
Belém 1
Bloomsburg 1
Brasília 1
Buffalo 1
Catania 1
Cocoa 1
Denver 1
Des Moines 1
Fraserburgh 1
Guatemala City 1
Hanoi 1
Hillsboro 1
Kingston 1
Lake Helen 1
Lecce 1
Manassas 1
Moreno Valley 1
Philadelphia 1
Pozzuoli 1
Queens 1
Quilicura 1
Rawalpindi 1
Saint Paul 1
San Antonio 1
San Francisco 1
Sanford 1
Sarno 1
Seattle 1
Shanghai 1
St John's 1
Sydney 1
Troina 1
Vernon 1
Vienna 1
Weatherly 1
Wilmington 1
Totale 157
Nome #
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma 134
BRAFV600E mutant metastatic colorectal cancer: Current advances in personalized treatment and future perspectives 35
Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approach 30
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial 29
Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world study 19
Adjuvant immunotherapy in high-risk stage II melanoma: real-world outcomes from a large multicenter retrospective study 11
Totale 258
Categoria #
all - tutte 1.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202518 0 0 2 1 3 3 2 1 1 0 3 2
2025/2026139 6 3 4 2 12 54 5 17 10 9 6 11
2026/2027101 0 17 43 41 0 0 0 0 0 0 0 0
Totale 258